45-year-old female with stage IV ovarian cancer. Evaluate for clinical trial. Is there measurable disease? Is there sites of disease that can be safely biopsied twice?Per outside report, clinical history ofPET avid area to left iliopsoas. Patient with history of recurrent ovarian cancer. ABDOMEN:LIVER, BILIARY TRACT: Within the left lobe of the liver, there is a peripheral enhancing lesion measuring 1.8 x 1.5 cm (series 17 image 27) that demonstrates restricted diffusion and FDG avidity on outside PET. Additional peripheral enhancing lesion lesion along the gallbladder fossa measures 1.1 x 1.1 centimeters (series 17 image 42) also demonstrates restricted diffusion FDG avidity on outside PET. Focus of arterial enhancement in segment 3 likely represents a flash filling hemangioma.SPLEEN: No significant abnormality noted.PANCREAS: No significant abnormality noted.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: No significant abnormality noted.RETROPERITONEUM, LYMPH NODES: No significant abnormality noted.BOWEL, MESENTERY: Omental and mesenteric nodules in the left abdomen compatible with carcinomatosis. Nodule that demonstrated FDG avidity on outside PET measures 1.4 x 0.8 cm (series 19 image 45).BONES, SOFT TISSUES: Enhancing nodule adjacent to the left iliopsoas muscle measures 1.2 x 1.1 cm (series 23 image 47) and is PET avid on outside PET. Additional enhancing nodule lateral to the left iliopsoas muscle (series 23 image 38). OTHER: No significant abnormality noted.PELVIS:UTERUS, ADNEXA: Postsurgical changes of hysterectomy and bilateral salpingo-oophorectomy. BLADDER: No significant abnormality noted.LYMPH NODES: Ill defined soft tissue nodularity anterior to the rectum compatible with carcinomatosis. BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1.Hepatic lesions suspicious for metastases.2.Omental and mesenteric nodularity in the abdomen and pelvis suspicious for carcinomatosis. 